Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can crestor cause sleep problems?Nucala patent expiration?Can entresto cause kidney problems?Can l lysine prevent cold sore outbreaks?Are there any herbal supplements that complement vascepa's benefits?
See the DrugPatentWatch profile for entresto
What happens if I stop taking Entresto? If you stop taking Entresto (sacubitril/valsartan) without consulting your doctor, it can lead to a sudden increase in blood pressure and a higher risk of cardiovascular events, including heart failure or heart attack [1]. Will symptoms return? According to the drug's manufacturer, Novartis, patients who stop taking Entresto may experience a return of their pre-treatment blood pressure levels, which can be elevated [2]. Some patients have reported difficulty breathing, swelling in their legs and feet, and dizziness when they stopped taking the medication. What if I've been taking Entresto for a long time? If you've been taking Entresto for an extended period, you may need to gradually taper off the medication to avoid withdrawal symptoms. Stopping the medication abruptly may cause blood pressure to rise rapidly, placing you at higher risk for cardiovascular complications. What should I do if I stop taking Entresto? If you decide to stop taking Entresto, it's essential to consult your doctor first to ensure a safe transition to an alternative treatment plan. Your doctor will help you manage your blood pressure and develop a plan to minimize the risks associated with stopping Entresto. What are the risks of sudden discontinuation? The risks of sudden discontinuation include: - Elevated blood pressure - Increased risk of cardiovascular events, such as heart failure or heart attack [1] - Difficulty breathing - Swelling in the legs and feet - Dizziness Who can help me? Consult a healthcare professional, such as your doctor or pharmacist, to discuss any concerns or questions you have about stopping Entresto. They can provide personalized advice and guidance to minimize potential risks. Sources: [1] DrugPatentWatch.com (Entresto (sacubitril/valsartan) patent information) [2] Novartis Pharmaceuticals Corporation (Entresto Patient Leaflet)
Other Questions About Entresto :